306934-76-9 Usage
Uses
As the exact uses and potential applications of 5-METHYL-6-PHENYLTHIENO[2,3-D]PYRIMIDIN-4-OL are still under investigation, the following applications are based on its potential pharmacological properties and interest in medicinal chemistry:
Used in Pharmaceutical Industry:
5-METHYL-6-PHENYLTHIENO[2,3-D]PYRIMIDIN-4-OL is used as a potential drug target for the development of new therapeutic agents. Its unique chemical structure and properties make it a promising candidate for the treatment of various diseases and disorders.
Used in Medicinal Chemistry Research:
5-METHYL-6-PHENYLTHIENO[2,3-D]PYRIMIDIN-4-OL is utilized as a subject of study in medicinal chemistry to explore its pharmacological properties and potential interactions with biological targets. This research aims to understand its mechanism of action and identify its potential therapeutic applications.
Check Digit Verification of cas no
The CAS Registry Mumber 306934-76-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,0,6,9,3 and 4 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 306934-76:
(8*3)+(7*0)+(6*6)+(5*9)+(4*3)+(3*4)+(2*7)+(1*6)=149
149 % 10 = 9
So 306934-76-9 is a valid CAS Registry Number.
InChI:InChI=1/C13H10N2OS/c1-8-10-12(16)14-7-15-13(10)17-11(8)9-5-3-2-4-6-9/h2-7H,1H3,(H,14,15,16)
306934-76-9Relevant academic research and scientific papers
Thieno[2,3-d]pyrimidines as antagonists of the glutamate receptors
Briel,Rybak,Kronbach,Unverferth
experimental part, p. 823 - 826 (2009/04/10)
Although the function of the kainate receptors in the brain is still not clear, they are increasingly defined as targets in the development of new classes of anti-epileptics. The thienopyrimidines described in this report were tested for their antagonisti
Efficient synthesis of14C-labeled 1H-pyrazolo[3,4-d]pyrimidine and related [4.3.0]-bicyclic pyrimidino systems
Ho, Jonathan Z.,Van Arsdale, Kyle R.,Braun, Matthew P.
scheme or table, p. 958 - 963 (2009/03/11)
In support of a research program aimed at discovering purine-related anticancer drug candidates, a method for the 14C-labeling of pyrazolopyrimidines utilizing the readily available labeled starting material, sodium [14C]formate, has been developed with a good overall yield. This new method was proven to be general in the preparation of other related [4.3.0]heterocycles containing N, O, and S atoms. A concise synthesis of a model compound, 8-aza-7-deaza-5′-[14C]noraristeromycin, was achieved utilizing this methodology as a key step.
